Lilly Bamlanivimab Antibody Playbook
This antibody playbook provides information for state, territorial and local public health programs to plan and operationalize a bamlanivimab antibody response to COVID-19. The sections of this document cover specific areas of COVID-19 antibody program planning and implementation, as well as links to resources to assist with those efforts.
Related Content
CHA Submits PAHPA Hearing Statement for the Record
The Facts About COVID-19 and Children
Creating a New Supply Chain for Continuous Albuterol
CHA Submits PAHPA Hearing Statement for the Record
CHA has submitted a statement for a Senate HELP Committee hearing to highlight how the national disaster and pandemic response infrastructure must prioritize children’s needs.
The Facts About COVID-19 and Children
Read the latest data on kids' COVID-19 cases, hospitalizations and vaccination numbers.
Creating a New Supply Chain for Continuous Albuterol
Children’s hospitals and their partners convene to ensure stable supply of albuterol for pediatric patients amid a critical shortage.
